Cyclooxygenase 2 expression and molecular alterations in Peutz-Jeghers hamartomas and carcinomas

Clinical Cancer Research

Volumn 9, Issue 8, 2003, Pages 3065-3072

  De Leng, Wendy W J ^a   Westerman, Anne Marie ^b   Weterman, Marian A J ^a   De Rooij, Felix W M ^b   Van Dekken, Herman ^b   De Goeij, Anton F P M ^c   Gruber, Stephen B ^d   Wilson, J H Paul ^b   Offerhaus, G Johan A ^a   Giardiello, Francis M ^e   Keller, Josbert J ^a,f  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIN D1; CYCLOOXYGENASE 2; KI 67 ANTIGEN; PROTEIN P21; PROTEIN P53;

ARTICLE; CANCER RISK; CHEMOPROPHYLAXIS; CHROMOSOME 17P; CHROMOSOME 19P; CHROMOSOME 5Q; CLINICAL ARTICLE; CONTROLLED STUDY; GENE MUTATION; GENE OVEREXPRESSION; GENE SEQUENCE; GERM LINE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROSATELLITE INSTABILITY; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; ONCOGENE K RAS; PEUTZ JEGHERS SYNDROME; PRECANCER; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BETA CATENIN; CARCINOMA; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 19; CHROMOSOMES, HUMAN, PAIR 5; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; CYCLOOXYGENASE 2; CYTOSKELETAL PROTEINS; DNA; DNA SEQUENCE, UNSTABLE; ENZYME INHIBITORS; GENES, RAS; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; KI-67 ANTIGEN; KINETICS; LOSS OF HETEROZYGOSITY; MEMBRANE PROTEINS; MICROSATELLITE REPEATS; MUTATION; PEUTZ-JEGHERS SYNDROME; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 12444302178     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Hemminki, A., Markie, D., Tomlinson, I., Avizienyte, E., Roth, S., Loukola, A., Bignell, G., Warren, W., Aminoff, M., Hoglund, P., Jarvinen, H., Kristo, P., Pelin, K., Ridanpaa, M., Salovaara, R., Toro, T., Bodmer, W., Olschwang, S., Olsen, A. S., Stratton, M. R., de la Chapelle, A., and Aaltonen, L. A. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature (Lond.), 391: 184-187, 1998.
2. Jenne, D. E., Reimann, H., Nezu, J., Friedel, W., Loff, S., Jeschke, R., Muller, O., Back, W., and Zimmer, M. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat. Genet., 18: 38-43, 1998.
3. Peutz, J. L. A. Over een zeer merkwaardige, gecombineerde familiaire polyposis van de slijmvliezen van den tractus intestinalis met die van de neuskeelholte en gepaard met eigenaardige pigmentaties van huid-en slijmvliezen. Ned. Maandschr. v. Geneeskunde, 10: 134-146, 1921.
4. Jeghers, H., Mc Kusick, V. A., and Katz, K. H. Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits. N. Engl. J. Med., 241: 993-1005, 1031-1036, 1949.
5. Hemminki, A. The molecular basis and clinical aspects of Peutz-Jeghers syndrome. Cell. Mol. Life Sci., 55: 735-750, 1999.
6. McGarrity, T. J., Kulin, H. E., and Zaino, R. J. Peutz-Jeghers syndrome. Am. J. Gastroenterol., 95: 596-604, 2000.
7. Giardiello, F. M., Brensinger, J. D., Tersmette, A. C., Goodman, S. N., Petersen, G. M., Booker, S. V., Cruz-Correa, M., and Offerhaus, J. A. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology, 119: 1447-1453, 2000.
8. Konishi, F., Wyse, N. E., Muto, T., Sawada, T., Morioka, Y., Sugimura, H., and Yamaguchi, K. Peutz-Jeghers polyposis associated with carcinoma of the digestive organs. Report of three cases and review of the literature. Dis. Colon Rectum, 30: 790-799, 1987.
9. Shepherd, N. A., Bussey, H. J., and Jass, J. R. Epithelial misplacement in Peutz-Jeghers polyps. A diagnostic pitfall. Am. J. Surg. Pathol., 11: 743-749, 1987.
10. Kinzler, K. W., and Vogelstein, B. Lessons from hereditary colorectal cancer. Cell, 87: 159-170, 1996.
11. Fodde, R., Smits, R., and Clevers, H. APC, signal transduction and genetic instability in colorectal cancer. Nat. Rev. Cancer, 1: 55-67, 2001.
12. Polyak, K., Hamilton, S. R., Vogelstein, B., and Kinzler, K. W. Early alteration of cell-cycle-regulated gene expression in colorectal neoplasia. Am. J. Pathol., 149: 381-387, 1996.
13. Giardiello, F. M., Offerhaus, G. J., and DuBois, R. N. The role of nonsteroidal anti-inflammatory drugs in colorectal cancer prevention. Eur. J. Cancer, 31A: 1071-1076, 1995.
14. Keller, J. J., and Giardiello, F. M. Chemopreventive strategies using NSAIDs and COX-2 inhibitors. Cancer Biol. Ther., in press, 2003.
15. Tsujii, M., and DuBois, R. N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83: 493-501, 1995.
16. Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., and DuBois, R. N. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell, 93: 705-716, 1998.
17. Chapple, K. S., Cartwright, E. J., Hawcroft, G., Tisbury, A., Bonifer, C., Scott, N., Windsor, A. C., Guillou, P. J., Markham, A. F., Coletta, P. L., and Hull, M. A. Localization of cyclooxygenase-2 in human sporadic colorectal adenomas. Am. J. Pathol., 156: 545-553, 2000.
18. Rossi, D. J., Ylikorkala, A., Korsisaari, N., Salovaara, R., Luukko, K., Launonen, V., Henkemeyer, M., Ristimaki, A., Aaltonen, L. A., and Makela, T. P. Induction of cyclooxygenase-2 in a mouse model of Peutz-Jeghers polyposis. Proc. Natl. Acad. Sci. USA, 99: 12327-12332, 2002.
19. Hemminki, A., Tomlinson, I., Markie, D., Jarvinen, H., Sistonen, P., Bjorkqvist, A. M., Knuutila, S., Salovaara, R., Bodmer, W., Shibata, D., de la Chapelle, A., and Aaltonen, L. A. Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis. Nat. Genet., 15: 87-90, 1997.
20. Gruber, S. B., Entius, M. M., Petersen, G. M., Laken, S. J., Longo, P. A., Boyer, R., Levin, A. M., Mujumdar, U. J., Trent, J. M., Kinzler, K. W., Vogelstein, B., Hamilton, S. R., Polymeropoulos, M. H., Offerhaus, G. J., and Giardiello, F. M. Pathogenesis of adenocarcinoma in Peutz-Jeghers syndrome. Cancer Res, 58: 5267-5270, 1998.
21. Entius, M. M., Keller, J. J., Westerman, A. M., van Rees, B. P., van Velthuysen, M. L., de Goeij, A. F., Wilson, J. H., Giardiello, F. M., and Offerhaus, G. J. Molecular genetic alterations in hamartomatous polyps and carcinomas of patients with Peutz-Jeghers syndrome. J. Clin. Pathol., 54: 126-131, 2001.
22. Miyaki, M., Iijima, T., Hosono, K., Ishii, R., Yasuno, M., Mori, T., Toi, M., Hishima, T., Shitara, N., Tamura, K., Utsunomiya, J., Kobayashi, N., Kuroki, T., and Iwama, T. Somatic mutations of LKB1 and β-catenin genes in gastrointestinal polyps from patients with Peutz-Jeghers syndrome. Cancer Res., 60: 6311-6313, 2000.
23. Wang, Z. J., Ellis, I., Zauber, P., Iwama, T., Marchese, C., Talbot, I., Xue, W. H., Yan, Z. Y., and Tomlinson, I. Allelic imbalance at the LKB1 (STK11) locus in tumours from patients with Peutz-Jeghers' syndrome provides evidence for a hamartoma-(adenoma)-carcinoma sequence. J. Pathol., 188: 9-13, 1999.
24. Westerman, A. M., Entius, M. M., Boor, P. P., Koole, R., de Baar, E., Offerhaus, G. J., Lubinski, J., Lindhout, D., Halley, D. J., de Rooij, F. W., and Wilson, J. H. Novel mutations in the LKB1/STK11 gene in Dutch Peutz-Jeghers families. Hum. Mutat., 13: 476-481, 1999.
25. Westerman, A. M., Entius, M. M., de Baar, E., Boor, P. P., Koole, R., van Velthuysen, M. L., Offerhaus, G. J., Lindhout, D., de Rooij, F. W., and Wilson, J. H. Peutz-Jeghers syndrome: 78-year follow-up of the original family. Lancet, 353: 1211-1215, 1999.
26. Keller, J. J., Offerhaus, G. J., Drillenburg, P., Caspers, E., Musler, A., Ristimaki, A., and Giardiello, F. M. Molecular analysis of sulindac-resistant adenomas in familial adenomatous polyposis. Clin. Cancer Res., 7: 4000-4007, 2001.
27. Baas, I. O., Mulder, J. W., Offerhaus, G. J., Vogelstein, B., and Hamilton, S. R. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J. Pathol., 172: 5-12, 1994.
28. Arber, N., Hibshoosh, H., Yasui, W., Neugut, A. I., Hibshoosh, A., Yao, Y., Sgambato, A., Yamamoto, H., Shapira, I., Rosenman, D., Fabian, I., Weinstein, I. B., Tahara, E., and Holt, P. R. Abnormalities in the expression of cell cycle-related proteins in tumors of the small bowel. Cancer Epidemiol. Biomark. Prev., 8: 1101-1105, 1999.
29. Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodriguez-Bigas, M. A., Fodde, R., Ranzani, G. N., and Srivastava, S. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res, 58: 5248-5257, 1998.
30. Entius, M. M., Keller, J. J., Drillenburg, P., Kuypers, K. C., Giardiello, F. M., and Offerhaus, G. J. Microsatellite instability and expression of hMLH-1 and hMSH-2 in sebaceous gland carcinomas as markers for Muir-Torre syndrome. Clin. Cancer Res., 6: 1784-1789, 2000.
31. Miyoshi, Y., Nagase, H., Ando, H., Horii, A., Ichii, S., Nakatsuru, S., Aoki, T., Miki, Y., Mori, T., and Nakamura, Y. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum. Mol. Genet., 1: 229-233, 1992.
32. DiGiuseppe, J. A., Hruban, R. H., Offerhaus, G. J., Clement, M. J., van den Berg, F. M., Cameron, J. L., and van Mansfeld, A. D. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma. Am. J. Pathol., 144: 889-895, 1994.
33. Poncin, J., Mulkens, J., Arends, J. W., and de Goeij, A. Optimizing the APC gene mutation analysis in archival colorectal tumor tissue. Diagn. Mol. Pathol., 8: 11-19, 1999.
34. Voeller, H. J., Truica, C. I., and Gelmann, E. P. β-Catenin mutations in human prostate cancer. Cancer Res., 58: 2520-2523, 1998.
35. Thun, M. J., Henley, S. J., and Patrono, C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J. Natl. Cancer Inst. (Bethesda), 94: 252-266, 2002.
36. Giardiello, F. M., Hamilton, S. R., Krush, A. J., Piantadosi, S., Hylind, L. M., Celano, P., Booker, S. V., Robinson, C. R., and Offerhaus, G. J. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med., 328: 1313-1316, 1993.
37. van Rees, B. P., and Ristimaki, A. Cyclooxygenase-2 in carcinogenesis of the gastrointestinal tract. Scand. J. Gastroenterol., 36: 897-903, 2001.
38. 2-dependent angiogenesis in Apc(Δ716) mouse intestinal polyps. Cancer Res., 62: 506-511, 2002.
39. Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., and Taketo, M. M. Suppression of intestinal polyposis in Apc Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell, 87: 803-809, 1996.
40. Steinbach, G., Lynch, P. M., Phillips, R. K., Wallace, M. H., Hawk, E., Gordon, G. B., Wakabayashi, N., Saunders, B., Shen, Y., Fujimura, T., Su, L. K., and Levin, B. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N. Engl. J. Med., 342: 1946-1952, 2000.
41. Jacoby, R. F., Seibert, K., Cole, C. E., Kelloff, G., and Lubet, R. A. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis. Cancer Res., 60: 5040-5044, 2000.
42. Sonoshita, M., Takaku, K., Oshima M., Sugihara, K., and Taketo, M. M. Cyclooxygenase-2 expression in fibroblasts and endothelial cells of intestinal polyps. Cancer Res., 62: 6846-6849, 2002.
43. Satoh, S., Daigo, Y., Furukawa, Y., Kato, T., Miwa, N., Nishiwaki, T., Kawasoe, T., Ishiguro, H., Fujita, M., Tokino, T., Sasaki, Y., Imaoka, S., Murata, M., Shimano, T., Yamaoka, Y., and Nakamura, Y. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat. Genet., 24: 245-250, 2000.
44. Esteller, M., Fraga, M. F., Guo, M., Garcia-Foncillas, J., Hedenfalk, I., Godwin, A. K., Trojan, J., Vaurs-Barriere, C., Bignon, Y. J., Ramus, S., Benitez, J., Caldes, T., Akiyama, Y. Yuasa, Y., Launonen, V., Canal, M. J., Rodriguez, R., Capella, G., Peinado, M. A., Borg, A., Aaltonen, L. A., Ponder, B. A., Baylin, S. B., and Herman, J. G. DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum. Mol. Genet., 10: 3001-3007, 2001.
45. Bartholomew, L. G., and Schutt, A. J. Systemic syndromes associated with neoplastic disease including cancer of the colon. Cancer (Phila.), 28: 170-174, 1971.
46. Hizawa, K., lida, M., Matsumoto, T., Kohrogi, N., Yao, T., and Fujishima, M. Neoplastic transformation arising in Peutz-Jeghers polyposis. Dis. Colon Rectum, 36: 953-957, 1993.